Novavax Inc (NVAX) reports significant revenue from Sanofi partnership and outlines strategic shifts to enhance future growth ...

The most recent trading session ended with Novavax (NVAX) standing at $12.91, reflecting a +1.77% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a ...

Novavax (NVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mayank Mamtani ...

We recently compiled a list of the 7 Best Under The Radar Stocks to Buy According to Analysts. In this article, we are going ...

We recently compiled a list of the 10 High-Flying Stocks to Buy Now. In this article, we are going to take a look at where ...

Shares of Novavax Inc. NVAX shed 5.04% to $12.63 Monday, on what proved to be an all-around great trading session for the ...

The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, ...

Novavax Inc (NASDAQ:NVAX) shares are bouncing around Wednesday, pulling back after popping in early trading. The company ...

Check the time stamp on this data. Updated AI-Generated Signals for Novavax Inc. (NVAX) available here: NVAX.

Novavax, Inc. (NVAX) announced Wednesday that the European Commission granted Marketing Authorization for Novavax's updated 2024-2025 ...

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

Novavax's vaccine is also authorized for use in the U.S., and is in line with guidance from the U.S. Food and Drug ...